Corium International

company

About

Corium International engages in the development of advanced transdermal drug delivery technologies and products.

  • 501 - 1000

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
$235M
Industries
Biotechnology,Health Care,Manufacturing,Pharmaceutical
Founded date
Jan 1, 1995
Number Of Employee
501 - 1000
Operating Status
Active

Corium International is a privately-owned company engaged in the research, development and manufacture of advanced transdermal drug delivery technologies and products. Using its proprietary delivery technologies and its development and manufacturing expertise, Corium has developed a number of active and passive transdermal products with enhanced therapeutic or safety profiles. This self-funded product pipeline spans several therapeutic areas and is in various stages of development. Corium also has several partner-funded products with small, medium and large pharmaceutical companies in various stages of development, ranging from manufacturing to research and development.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$235M
Corium International has raised a total of $235M in funding over 2 rounds. Their latest funding was raised on Sep 27, 2021 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 27, 2021 Debt Financing $235M 1 Hercules Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Corium International is funded by 1 investors. Hercules Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Hercules Capital Yes Debt Financing